NYSE:DNA
Ginkgo Bioworks Stock Company Profile
$0.96
+0.0951 (+11.04%)
At Close: May 03, 2024
Information
27 Drydock Avenue, 8th Floor
Boston MA 02210
877 422 5362
www.ginkgobioworks.com
Industry: Biotechnology
Sector: Healthcare
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
